ArticleFrontiers in pharmacology2018

Targeted Next-Generation Sequencing Identifies Actionable Targets in Estrogen Receptor Positive and Estrogen Receptor Negative Endometriod Endometrial Cancer.

Siti Syazani Suhaimi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.